Zdrowie i gospodarka · 11/07/2018
FDA Requests Public Comment on Proposed Collection of Information for Prescription Drug User Fee Act Products
The Food and Drug Administration is seeking public input on a proposed collection of information related to formal meetings with sponsors and applicants for Prescription Drug User Fee Act products, as required by the Paperwork Reduction Act of 1995.
Source: Federal Register — Food and Drug AdministrationOpen original release →